196 related articles for article (PubMed ID: 35361778)
1. Usp8 promotes tumor cell migration through activating the JNK pathway.
Zhao Y; Peng D; Liu Y; Zhang Q; Liu B; Deng Y; Ding W; Zhou Z; Liu Q
Cell Death Dis; 2022 Mar; 13(3):286. PubMed ID: 35361778
[TBL] [Abstract][Full Text] [Related]
2. The ubiquitin-specific protease USP8 deubiquitinates and stabilizes Cx43.
Sun J; Hu Q; Peng H; Peng C; Zhou L; Lu J; Huang C
J Biol Chem; 2018 May; 293(21):8275-8284. PubMed ID: 29626091
[TBL] [Abstract][Full Text] [Related]
3. The oncogenic role of ubiquitin specific peptidase (USP8) and its signaling pathways targeting for cancer therapeutics.
Islam MT; Chen F; Chen H
Arch Biochem Biophys; 2021 Apr; 701():108811. PubMed ID: 33600786
[TBL] [Abstract][Full Text] [Related]
4. High Expression of Ubiquitin-Specific Protease 8 (USP8) Is Associated with Poor Prognosis in Patients with Cervical Squamous Cell Carcinoma.
Yan M; Zhao C; Wei N; Wu X; Cui J; Xing Y
Med Sci Monit; 2018 Jul; 24():4934-4943. PubMed ID: 30010158
[TBL] [Abstract][Full Text] [Related]
5. Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma.
Kim Y; Shiba-Ishii A; Nakagawa T; Iemura SI; Natsume T; Nakano N; Matsuoka R; Sakashita S; Lee S; Kawaguchi A; Sato Y; Noguchi M
Oncogene; 2018 Oct; 37(40):5387-5402. PubMed ID: 29880877
[TBL] [Abstract][Full Text] [Related]
6. USP8 is a novel target for overcoming gefitinib resistance in lung cancer.
Byun S; Lee SY; Lee J; Jeong CH; Farrand L; Lim S; Reddy K; Kim JY; Lee MH; Lee HJ; Bode AM; Won Lee K; Dong Z
Clin Cancer Res; 2013 Jul; 19(14):3894-904. PubMed ID: 23748694
[TBL] [Abstract][Full Text] [Related]
7. USP8: a novel therapeutic target for Cushing's disease.
Jian F; Cao Y; Bian L; Sun Q
Endocrine; 2015 Nov; 50(2):292-6. PubMed ID: 26162929
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.
Panner A; Crane CA; Weng C; Feletti A; Fang S; Parsa AT; Pieper RO
Cancer Res; 2010 Jun; 70(12):5046-53. PubMed ID: 20484045
[TBL] [Abstract][Full Text] [Related]
9. The deubiquitinating enzyme USP8 promotes trafficking and degradation of the chemokine receptor 4 at the sorting endosome.
Berlin I; Higginbotham KM; Dise RS; Sierra MI; Nash PD
J Biol Chem; 2010 Nov; 285(48):37895-908. PubMed ID: 20876529
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin-specific protease USP8 directly deubiquitinates SQSTM1/p62 to suppress its autophagic activity.
Peng H; Yang F; Hu Q; Sun J; Peng C; Zhao Y; Huang C
Autophagy; 2020 Apr; 16(4):698-708. PubMed ID: 31241013
[TBL] [Abstract][Full Text] [Related]
11. USP8 suppresses death receptor-mediated apoptosis by enhancing FLIP
Jeong M; Lee EW; Seong D; Seo J; Kim JH; Grootjans S; Kim SY; Vandenabeele P; Song J
Oncogene; 2017 Jan; 36(4):458-470. PubMed ID: 27321185
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal cross-regulation between RNF41 and USP8 controls cytokine receptor sorting and processing.
De Ceuninck L; Wauman J; Masschaele D; Peelman F; Tavernier J
J Cell Sci; 2013 Aug; 126(Pt 16):3770-81. PubMed ID: 23750007
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting USP8 overcomes hepatocellular carcinoma resistance via suppressing receptor tyrosine kinases.
Zhu Y; Xu J; Hu W; Wang F; Zhou Y; Gong W; Xu W
Aging (Albany NY); 2021 Jun; 13(11):14999-15012. PubMed ID: 34081623
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinase USP8 increases ID1 stability and promotes esophageal squamous cell carcinoma tumorigenesis.
Li L; Liu Y; Zhao Y; Feng R; Li Y; Yu X; Liu Z; Wang L
Cancer Lett; 2022 Aug; 542():215760. PubMed ID: 35636624
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-specific protease 8 is a novel prognostic marker in early-stage lung adenocarcinoma.
Kim Y; Shiba-Ishii A; Nakagawa T; Husni RE; Sakashita S; Takeuchi T; Noguchi M
Pathol Int; 2017 Jun; 67(6):292-301. PubMed ID: 28544031
[TBL] [Abstract][Full Text] [Related]
16. Effect of deubiquitinase USP8 on hypoxia/reoxygenation‑induced inflammation by deubiquitination of TAK1 in renal tubular epithelial cells.
Zhang Y; Luo Y; Wang Y; Liu H; Yang Y; Wang Q
Int J Mol Med; 2018 Dec; 42(6):3467-3476. PubMed ID: 30221684
[TBL] [Abstract][Full Text] [Related]
17. USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-β receptor TβRII.
Xie F; Zhou X; Li H; Su P; Liu S; Li R; Zou J; Wei X; Pan C; Zhang Z; Zheng M; Liu Z; Meng X; Ovaa H; Ten Dijke P; Zhou F; Zhang L
EMBO J; 2022 Aug; 41(16):e108791. PubMed ID: 35811497
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-specific protease 8 (USP8/UBPy): a prototypic multidomain deubiquitinating enzyme with pleiotropic functions.
Dufner A; Knobeloch KP
Biochem Soc Trans; 2019 Dec; 47(6):1867-1879. PubMed ID: 31845722
[TBL] [Abstract][Full Text] [Related]
19. Regulation of ubiquitin-specific processing protease 8 suppresses neuroinflammation.
Zhu L; Bi W; Lu D; Zhang C; Shu X; Wang H; Qi R; Shi Q; Lu D
Mol Cell Neurosci; 2015 Jan; 64():74-83. PubMed ID: 24861766
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of ubiquitin-specific protease 8 autoinhibition by the WW-like domain.
Kakihara K; Asamizu K; Moritsugu K; Kubo M; Kitaguchi T; Endo A; Kidera A; Ikeguchi M; Kato A; Komada M; Fukushima T
Commun Biol; 2021 Nov; 4(1):1272. PubMed ID: 34750505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]